Early afterdepolarizations (EADs) associated with prolongation of the cardiac action potential (AP) can create heterogeneity of repolarization and premature extrasystoles, triggering focal and reentrant arrhythmias. Because the L-type Ca2+ current (ICa,L) plays a key role in both AP prolongation and EAD formation, L-type Ca2+ channels (LTCCs) represent a promising therapeutic target to normalize AP duration (APD) and suppress EADs and their arrhythmogenic consequences. We used the dynamic-clamp technique to systematically explore how the biophysical properties of LTCCs could be modified to normalize APD and suppress EADs without impairing excitation–contraction coupling. Isolated rabbit ventricular myocytes were first exposed to H2O2 or moderate hypokalemia to induce EADs, after which their endogenous ICa,L was replaced by a virtual ICa,L with tunable parameters, in dynamic-clamp mode. We probed the sensitivity of EADs to changes in the (a) amplitude of the noninactivating pedestal current; (b) slope of voltage-dependent activation; (c) slope of voltage-dependent inactivation; (d) time constant of voltage-dependent activation; and (e) time constant of voltage-dependent inactivation. We found that reducing the amplitude of the noninactivating pedestal component of ICa,L effectively suppressed both H2O2- and hypokalemia-induced EADs and restored APD. These results, together with our previous work, demonstrate the potential of this hybrid experimental–computational approach to guide drug discovery or gene therapy strategies by identifying and targeting selective properties of LTCC.
Early afterdepolarizations (EADs) are arrhythmogenic membrane potential oscillations that occur before repolarization of the cardiac action potential (AP) is complete. Although the mechanistic link between EADs in single cells and triggered arrhythmias in the heart is still a subject of intense investigation (Wit and Rosen, 1983; Rosen, 1988; Antzelevitch and Sicouri, 1994; El-Sherif et al., 1996; Yan et al., 2001; Xie et al., 2010; Yang et al., 2010), it is firmly established that EADs are capable of triggering fatal arrhythmias such as polymorphic ventricular tachycardia, torsade de pointes, and ventricular fibrillation (Yan et al., 2001; Choi et al., 2002; Wu et al., 2002; Antzelevitch, 2007; Bapat et al., 2012), which often exhibit a mixture of focal and reentrant mechanisms (Asano et al., 1997; Sato et al., 2009; Weiss et al., 2010; Chang et al., 2012). Not only are EADs capable of generating triggered activity to produce focal arrhythmias, but they are also associated with a prolonged AP duration (APD). Thus, they can markedly increase dispersion of refractoriness in tissue, predisposing to initiation of reentry (Sato et al., 2009; Weiss et al., 2010; Chang et al., 2012).
The onset of EADs (i.e., the reversal of the normal repolarization phase of the AP) occurs within a range of the membrane potentials where the steady-state activation and inactivation curves of the L-type Ca2+ current (ICa,L) overlap, known as the ICa,L window current region (January et al., 1988). Within this membrane potential range, ICa,L reactivation plays a key role in reversing the normal repolarization phase during EAD formation (January et al., 1988). Although other ionic currents also participate in EAD formation, a regenerative inward current such as ICa,L is required for EADs to propagate in the tissue (Zeng and Rudy, 1995; Chang et al., 2012). Using the dynamic-clamp technique (Dorval et al., 2001) in isolated rabbit ventricular myocytes, we recently demonstrated that EADs are highly sensitive to subtle changes in the half-activation or half-inactivation potentials of ICa,L, suggesting that a reduction of the ICa,L window current may represent an effective maneuver to suppress EADs and normalize APD without blocking the early peak ICa,L required to maintain a normal excitation–contraction coupling (Madhvani et al., 2011). The dynamic clamp is a powerful technique that allows one to introduce a model conductance, such as ICa,L, with programmable properties into a cell in real time to study its effects on AP characteristics (Fig. 1 E). The proof-of-concept provided by our initial study (Madhvani et al., 2011) prompted us to perform a comprehensive analysis of biophysical parameters influencing the time- and voltage-dependent properties of the window (late) ICa,L to identify whether additional parameters could be modified to suppress EAD formation and normalize APD. Accordingly, we systematically investigated the slopes of the voltage dependence of activation and inactivation, the noninactivating (or very slowly inactivating) late pedestal current, and the time constants of activation and inactivation, which shape the ICa,L window current (Fig. 1, A and C) during the cardiac AP.
The results demonstrate that of all the ICa,L biophysical parameters explored in this and previous work (Madhvani et al., 2011), three stand out as highly effective targets both to suppress EAD formation and normalize APD to reduce dispersion of repolarization: the half-activation and half-inactivation potentials and the noninactivating pedestal current. Collectively, these findings provide a drug discovery target to search for new antiarrhythmic agents to suppress EAD-mediated arrhythmias. Moreover, this study recapitulates a novel hybrid experimental–computational approach incorporating the dynamic-clamp technique to predict how subtle alterations in biophysical properties of ionic currents such as ICa,L affect cardiac electrophysiology and arrhythmogenic phenomena.
MATERIALS AND METHODS
All animal-handling protocols were approved by the UCLA Institutional Animal Care and Use Committee and conformed to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health.
3–4-mo-old New Zealand male rabbits were euthanized by an intravenous injection of 1,000 U heparin sulfate and 100 mg/kg sodium pentobarbital; adequacy of anesthesia was confirmed by the lack of pedal withdrawal reflex, corneal reflex, and motor response to pain stimuli. Ventricular myocytes were dissociated using a retrograde Langendorff perfusion system as described previously (Chen et al., 2003), and washed and bathed in Tyrode’s solution containing (mM): 136 NaCl, 5.4 KCl, 1 MgCl2, 0.33 NaH2PO4, 1.8 CaCl2, 10 glucose, and 10 HEPES, adjusted to pH 7.4. The intracellular solution contained (mM): 110 K-aspartate, 30 KCl, 5 NaCl, 10 HEPES, 0–0.1 EGTA, 5 MgATP, 5 creatine phosphate, and 0–0.05 cAMP adjusted to pH 7.2. EADs were induced by perfusing 600 µM H2O2 or reducing the external [K+] from 5.4 to 2.7 mM. All chemicals were purchased from Sigma-Aldrich. All electrophysiological recordings were performed using an Axopatch 200B amplifier (Axon Instruments) in current-clamp mode at ∼34–36°C using 1–2-MΩ borosilicate pipettes (Warner Instruments). Data were acquired and analyzed using custom-made software (G-Patch; Analysis).
Under dynamic-clamp mode, a virtual ICa,L with the properties of the native ICa,L is injected into the myocytes. To predict ICa,L and its Ca2+-dependent inactivation, our ventricular myocyte model also computes intracellular Ca2+ cycling. To predict the spatiotemporal distribution of intracellular calcium, average [Ca2+] was computed in four different cellular compartments, namely the “submembrane space” in proximity of the sarcolemma (Cs), the “bulk myoplasm,” the “junctional SR,” and “network SR,” as described previously (Shiferaw et al., 2003; Mahajan et al., 2008; Madhvani et al., 2011). The main Ca2+-regulated ionic conductance was also included in the model, i.e., the fast sodium current (INa), the Na+/K+ pump current (INaK), the Na+/Ca2+ exchange current (INCX), and the Ca2+-dependent slow component of the delayed rectifier potassium channel (IKs). Calcium-modulated currents sense the [Ca2+] at submembrane space (Cs), which is higher than the global [Ca2+] (Ci) (Weber et al., 2002). The average Cs is used to calculate Ca2+-dependent inactivation in the ICa,L formulation, whereas Ci was acquired during the course of the experiments to predict the amplitude and shape of the Cai transient.
In brief, the Ca2+ flux into the cell caused by ICa,L is given by:
where Cs is the submembrane Ca2+ concentration in units of millimolar, PCa (0.00054 cm/s) is the Ca2+ channel permeability, Vm is the membrane potential, F is the Faraday constant, and T is temperature.
PO was formulated as:
where d is the voltage-dependent activation gate, f is the VDI gate, and q is the Ca2+-dependent inactivation gate. The steady states of these gating variables as functions of the membrane potential (Vm) were formulated as follows:
where dhalf and fhalf are the potentials at half-maximum of activation and inactivation, respectively; pdest is the noninactivating pedestal of the inactivation gate; and dslope/fslope are the steepness of the voltage dependence of activation and inactivation, respectively. These two parameters are called slope factors (k) in this study, and are related to effective charge (z) by RT/z, where R is the gas constant and T is temperature. Cs is the submembrane [Ca2+]; Cst is the affinity for Ca2+ of the inactivation gate; τd and τf are the time constants of the d gate and the f gate, respectively; and a1, a2, b1, b2, b3, and b4 are additional factors used for fitting. The control parameters in the ICa,L formulation were determined by fitting formulated current to experimental nifedipine-sensitive ICa,L records (Madhvani et al., 2011) using Berkeley Madonna and then implemented for dynamic clamp in RTXI (http://www.rtxi.org; Lin et al., 2010). In each experiment, as soon as the whole-cell configuration was obtained, the cell capacitance of the myocyte was measured (usually ranging within 100–150 pF) and entered as one of the parameters of the dynamic-clamp model to scale the computed ICa,L accordingly to the cell size. The sampling/computation frequency was 10 kHz.
In some experiments, 10% of the computed slow component of the delayed rectifier K+ current (IKs) was injected together with ICa,L. IKs was modeled as in Mahajan et al. (2008).
APD at 90% repolarization (APD90) was calculated using custom-made software, whereas EAD amplitude was calculated manually by measuring the difference in Vm from the local minimum where dV/dt is 0 to the peak of the EAD where dV/dt is also 0. In APs that displayed multiple EADs, only the EAD with the largest voltage excursion was included in the analysis. EAD occurrence is reported as the percentage of APs that displayed at least one EAD. Error bars show the SEM.
Online supplemental material
Online supplemental figures show the effects of varying the slope (k) of the steady-state inactivation curve (Fig. S1) and the predicted Cai transient before and after reduction of ICa,L pedestal (Fig. S2) under the dynamic clamp. Fig. S3 demonstrates that the reduction of ICa,L noninactivating component effectively suppressed EADs under hypokalemia condition. Fig. S4 shows results from computer simulation using a model of rabbit myocytes with properties of M, endo, and epi cell layers. Table S1 reports the mean values for EAD occurrence and APD90 for different ICa,L activation and inactivation time constants. Table S2 shows the biophysical parameters of ICa,L in the dynamic-clamp model for control, H2O2, and hypokalemia conditions. Tables S3 and S4 provide parameter values for maximal ionic conductances used in the computer simulation using a model of rabbit AP with properties of epi, endo, and M cell layers.
Sensitivity of EAD occurrence to the noninactivating component of ICa,L
In our previous study (Madhvani et al., 2011), we demonstrated that modest shifts (<5 mV) in the half-activation and half-inactivation potentials of ICa,L, which reduce the overlap between steady-state activation and inactivation curves (i.e., the window current region; Fig. 1 A), potently suppressed EADs, without adversely altering APD or the computed intracellular Cai transient. However, other parameters also affect the ICa,L window current and its ability to contribute to EAD formation. Using dynamic clamp, we have explored the extent to which the other properties affecting activation and inactivation contribute to EAD formation.
To induce an EAD regimen, myocytes were paced at 5-s cycle length under current-clamp mode and superfused with 600 µM H2O2 until EADs appeared consistently. The native ICa,L was then blocked with 20 µM nifedipine, which eliminated EADs and markedly shortened the APD (Fig. 1 D). Next, the dynamic clamp was engaged to replace the native ICa,L (blocked by nifedipine) by injecting, in real time, a ICa,L computed from Eqs.1–8, causing EADs to reappear (Fig. 1 E). The membrane potential of the myocyte was continuously sampled and fed into the dynamic-clamp model, creating a bidirectional relationship between the cell and the model, in real time (Fig. 1 E). The injected ICa,L had the properties of the native ICa,L in the presence of 600 µM H2O2 (Madhvani et al., 2011). Importantly, all dynamic-clamp experiments were performed in the continuous presence of H2O2 or hypokalemia, maintaining a pathological state that resulted in EAD formation.
The inactivation of ICa,L caused by voltage- and Ca2+-dependent mechanisms (voltage-dependent inactivation, VDI, and Ca2+-dependent inactivation, CDI, respectively) (Catterall, 2000) is incomplete during the time course of an AP. This noninactivating component was previously found to be elevated (from ∼3 to ∼10% of the peak current) in myocytes exposed to an EAD-promoting regimen (H2O2) (Madhvani et al., 2011), suggesting that this residual current contributes to EAD formation by effectively increasing ICa,L window region (Fig. 1, A and B). Motivated by these pieces of evidence, we directly probed EAD sensitivity to changes in the amplitude ICa,L noninactivating component (pedestal) (Rose et al., 1992; Qu and Chung, 2012). As demonstrated in Fig. 2, after inducing EADs in a myocyte by H2O2 superfusion (Fig. 2 B), the EADs were abolished by nifedipine (Fig. 2 C) and reconstituted by injecting a virtual ICa,L (Fig. 2 D). Under these conditions, APs were markedly prolonged, displaying a consistent EAD regimen, although with oscillations that tended to be smaller in amplitude than the ones typically observed experimentally (Fig. 2). Because nifedipine abolishes the Cai transient, which is important for activating IKs (Tohse, 1990; Nitta et al., 1994), we compensated by adding 10% of the computed IKs to the injected current. This maneuver reduced the voltage plateau into a range promoting greater ICa,L reactivation and larger EAD oscillations (Fig. 2 E), more closely resembling H2O2-induced EADs before nifedipine blockade. The reduction of the ICa,L pedestal from 10 to 4% of the peak completely suppressed EAD occurrence and shortened the APD90 from 1,090 ± 80 ms to 197 ± 3 ms (Figs. 2 F and 3) whether or not EAD amplitude was increased by adding IKs. Importantly, the reduction of the ICa,L pedestal suppresses the EAD regimen without attenuating the amplitude of the predicted Cai transient (Fig. S2).
These results indicate that the reduction of the noninactivating ICa,L pedestal current can be an effective therapeutic strategy to suppress EADs.
Sensitivity of EADs to the steepness of steady-state activation and inactivation curves
Another set of parameters affecting the ICa,L window current region are the steepness of the voltage dependence of activation and inactivation. However, modification of either parameter did not completely suppress EADs, nor did it restore normal APD, in contrast to the consequences of noninactivating pedestal current reduction. After reconstitution of the EADs with dynamic clamp in the presence of H2O2 in the superfusate, we first examined the effects of altering the slope factor (k) of the voltage dependence of activation from 4 mV (effective valence, z = 5.7 e0) to 1 mV (z = 25.6 e0) or 8 mV (z = 3.2 e0) to increase or decrease, respectively, the steepness of the voltage dependence of activation (Fig. 4 A). We found that, at greater steepness, EAD amplitudes decreased from 5.6 ± 0.7 mV to 3.1 ± 1 mV (for k = 2 mV, z = 12.8 e0) or 2.6 ± 0.8 mV (k = 1 mV, z = 25.6 e0) (Fig. 4, B and C). Also, for the steepest slope (k = 1 mV, z = 25.6 e0), the APD became prolonged such that, in some cases, the AP failed to repolarize before the next pacing stimulus (APD > 5 s) (Fig. 4 B). Conversely, when the effective charge of the activation curve was reduced from k = 4 mV (z = 6.4e0) to k = 6 mV (z = 4.3e0), EAD amplitude increased from 5.6 ± 0.7 mV to 12.3 ± 1.4 mV (Fig. 4, B and C). This effect was even more pronounced for k = 8 mV (z = 3.2e0), such that the mean EAD amplitude increased to 21.4 ± 2 mV (Fig. 4, B and C), although no significant changes in percentage of APs with EADs were observed (Fig. 4 D), and APD90 remained prolonged for these maneuvers (Fig. 4 E).
We also investigated the effects of changing the slope of the voltage dependence of inactivation (Fig. S1 A) by increasing or decreasing the effective charge to k = 1 mV (z = 25.6 e0) or k = 8 mV (z = 3.2 e0), respectively. We did not observe a significant difference in either EAD amplitude or in percentage of APs with EADs (Fig. S1, C and D). APD90 prolonged from 1,104 ± 319 ms to 3,140 ± 771 ms (Fig. S1, B and E) as the steepness of the inactivation curve was reduced from k = 4 mV (z = 6.4 e0) to k = 8 mV (z = 3.2 e0) (Fig. S1 A).
Sensitivity of EADs to the kinetics of ICa,L activation and inactivation
We next studied the effects of altering the time constants of ICa,L activation and inactivation on EAD formation during oxidative stress. Overall, we found that changes in the rates of ICa,L activation or inactivation by up to 10-fold had limited efficacy at suppressing EADs induced by H2O2 (Figs. 5 and 6).
Specifically, in the presence of H2O2, slowing ICa,L activation by twofold (τd × 2) maintained an average APD90 of 1,550 ± 130 ms, and EAD occurrence remained high at 91 ± 4% (Table S1). A 10-fold slowing of ICa,L activation (τd × 10) prolonged APD90 from 1,376 ± 200 ms to 2,711 ± 548 ms, whereas EAD occurrence increased from 76 ± 8% to 100% of APs. Conversely, increasing the rate of ICa,L activation by twofold (τd × 0.5; Table S1) or by 10-fold (τd × 0.1) had only a modest impact on both APD90 (1,122 ± 126 ms or 1,104 ± 165 ms) and EAD occurrence (79 ± 15% or 77 ± 10%), respectively (Fig. 5 and Table S1).
When the rate of VDI in the dynamic-clamp model was increased by twofold (τf × 0.5), neither APD90 (from 1,376 ± 200 ms to 1,838 ± 435 ms) nor EAD occurrence (from 76 ± 8% to 70 ± 16%) was dramatically altered (Table S1). Accelerating VDI by 10-fold (τf × 0.1; Fig. 6 A) increased APD90 (to 2,433 ± 290 ms) (Fig. 6 D), and EAD occurrence remained high (85 ± 8%; Fig. 6 C and Table S1). Conversely, decreasing the rate of VDI by twofold (τf × 2; Fig. 6 A) reduced EAD occurrence to 24 ± 14% (Fig. 6 C), but APD90 remained prolonged (802 ± 183 ms; Fig. 6 D). Decelerating inactivation by 10-fold (τf × 10), on the other hand, did not reduce EAD occurrence (73 ± 24% of APs), and significantly prolonged APD90 (1,506 ± 102 ms; Fig. 6, C and D, and Table S1).
Reduction of ICa,L noninactivating component is effective at suppressing EADs under hypokalemia, another EAD-favoring condition
In addition to our previously reported finding that EADs could be suppressed, and the APD could be normalized, by modest shifts of the half-voltage of steady-state activation or inactivation (Madhvani et al., 2011), the present results indicate that suppressing the noninactivating ICa,L pedestal current is an effective strategy, whereas the modification of other biophysical parameters affecting the steepness or kinetics of activation and inactivation is unreliable. To ascertain whether reducing ICa,L pedestal is effective at suppressing EADs caused by a mechanism other than oxidative stress, we also examined its potency at suppressing hypokalemia-induced EADs. As shown previously (Sato et al., 2010), lowering extracellular [K+] from 5.4 to 2.7 mM readily induced EADs within 5–10 min. Using the same dynamic-clamp approach, the endogenous nifedipine-sensitive current was replaced by a virtual ICa,L, the parameters of which were modified to simulate the effects of hypokalemia on the native ICa,L (Table S2). The virtual ICa,L reconstituted EADs were greatly suppressed (n = 3) or completely abolished (n = 2) by reducing the pedestal component of the virtual ICa,L from 5% to ≤0.5% (Fig. S3, C and D).
Effects of noninactivating pedestal of ICa,L on simulated EADs in epicardial, endocardial, and M cell types
Across the ventricular wall, there are regional differences in the ionic basis underlying ventricular APs (Antzelevitch et al., 1991; Antzelevitch and Sicouri, 1994). To explore how these regional differences affect the ability of a therapeutic reduction in the ICa,L pedestal to suppress EADs, we modified the rabbit ventricular AP model to simulate epicardial, endocardial, and M cell layer APs, respectively. When paced at a 5-s cycle length under control conditions, with a 3% ICa,L pedestal current (Fig. S4 A), APD90 averaged 229, 258, and 268 ms for the epicardial, endocardial, and M cells, respectively. We then simulated the effects of H2O2 as described above, including increasing the ICa,L pedestal current to 6%. The APD90 prolonged to 540, 504, and 811 ms, respectively, and EADs appeared in all three cell types (Fig. S4 B). When the ICa,L pedestal current was reduced to 0%, while maintaining all other H2O2 effects, APD90 shortened to 273, 293, and 309 ms, respectively, and EADs disappeared (Fig. S4 C). Thus, suppressing the ICa,L pedestal current was effective at eliminating EADs regardless of transmural AP heterogeneity.
Although many ionic currents can contribute to EAD formation, reactivation of ICa,L plays a central role in providing a regenerative inward current required for EADs to propagate, thereby causing triggered activity in multicellular tissue (January et al., 1988; January and Riddle, 1989). The main finding of the present study is that, even though H2O2 is likely to promote EADs by affecting multiple ionic currents such as late INa (Song et al., 2006), the modification of ICa,L is sufficient to prevent EADs even in the presence of H2O2. Furthermore, this intervention does not diminish the amplitude of the predicted Cai transient (Fig. S2) and therefore is expected to maintain normal cell contractility. Conventional Ca2+ channel blockers such as nifedipine, which indiscriminately block both peak and window ICa,L, are highly effective at suppressing EADs (e.g., Fig. 1 D). However, by blocking peak ICa,L, these drugs also potently suppress excitation–contraction coupling, precluding clinical usefulness for EAD suppression.
In this study, we applied the dynamic-clamp technique to systematically evaluate the hypothesis that EADs can be suppressed by selectively targeting the biophysical properties regulating the ICa,L window current. Fig. 7 summarizes the effects of the various parameter changes on both APD and EAD occurrence, illustrating that three parameter modifications (depolarizing shift of the half-activation potential, hyperpolarizing shift of the half-inactivation potential, and reduction of the pedestal current) both effectively suppress EADs and restore APD toward a normal value. From these findings, we predict that the ideal Ca2+ channel agent for suppressing EAD-mediated arrhythmias (drugs or genetic intervention) would leave peak ICa,L, hence excitation–contraction coupling, intact but selectively suppress late ICa,L in the window region. An important novel contribution of the present study is the finding that the ICa,L pedestal current has an equivalent promise to the half-activation and half-inactivation potentials as a novel anti-arrhythmic target to suppress EAD formation, which is robust across the spectrum of simulated transmural AP differences in the ventricular epicardial, M cell, and endocardial layers (Fig. S3). Moreover, it is effective for different mechanisms of EAD generation, as H2O2 primarily causes EADs by increasing inward currents including late INa and ICa,L as a result of oxidative CaMKII activation (Ward and Giles, 1997; Xie et al., 2009; Wagner et al., 2011), whereas hypokalemia causes EADs by reducing K+ conductances, i.e., IKr, and Na+/K+ ATPase activity, which in turn causes accumulation of intracellular Na+ and Ca2+. The finding that selective blockade of the ICa,L pedestal has potent EAD-suppressing effects is particularly intriguing because of the precedent in Na+ channels, in which selective blockers of the late Na+ current (INa), which leave the peak INa intact, are already in clinical use (Karwatowska-Prokopczuk et al., 2013). Given the overall structural similarities between Na+ and Ca2+ channels, the likelihood that analogous agents that selectively block late ICa,L can also be identified seems high. Moreover, because late INa can also play an important role in EAD formation (Xie et al., 2009; Yang et al., 2012), we can further speculate that the combination of a late INa blocker with a late ICa,L blocker might be a particularly efficacious anti-arrhythmic combination to prevent EAD-mediated arrhythmias.
The effects of modifying various ICa,L parameters on the APD and EAD occurrence observed in this study can be understood in terms of the dynamical theory of EAD formation as a dual Hopf-homoclinic bifurcation (Tran et al., 2009; Qu et al., 2013). In this theory, the membrane voltage oscillations characterizing EADs depend critically on the amount of time that the membrane potential dwells in the window region during repolarization. This dwell time must be long enough for the growth rate of ICa,L to overcome counterbalancing repolarizing currents such as IKs, thereby generating the upstroke of the EAD. As the membrane potential exceeds the voltage for peak ICa,L (∼0 mV), the diminishing amplitude of ICa,L and voltage-dependent growth of IKs force the repolarization phase of the EAD, with this tug-of-war generating successive oscillations. Our results show that EAD amplitude is a function of the slope of the voltage dependence of ICa,L activation (Fig. 4), consistent with the dynamical theory stating that membrane oscillations (EADs) occur because of instability of the ICa,L in the window current voltage range via a Hopf bifurcation (Tran et al., 2009; Qu et al., 2013). EAD formation is more susceptible to interventions that limit the maximum steady-state amplitude that the late ICa,L can achieve during repolarization (shifts in half-activation and half-inactivation potential and pedestal current) than to interventions that change the rate of growth (time constants of activation and inactivation) or shape of the window ICa,L (slopes of inactivation and inactivation). Although EAD occurrence could be diminished with small changes in steady-state parameters (<5-mV shifts in half-activation and half-inactivation potential or reduction in the pedestal current; Fig. 7), kinetic parameters required order-of-magnitude changes to produce modest effects, often causing excessive changes in APD (Figs. 4–7 and S1).
Limitations and Implications
There are several limitations in this experimental–computational approach:
Rabbit versus human ventricular myocytes.
This study was performed in rabbit ventricular myocytes, which differ in some respects from human myocytes. Although the results from this study need to be validated in human myocytes, previous studies have shown that the ICa,L properties are generally similar in both species (Grandi et al., 2010; Verkerk et al., 2011), suggesting that suppression of ICa,L noninactivating component could be an effective therapeutic strategy.
To study how the biophysical properties of ICa,L affect EAD formation, it was required to replace the endogenous ICa,L with a computed, “virtual” ICa,L with tunable parameters under dynamic-clamp conditions. The current injected under the dynamic clamp, although incorporating Ca2+-dependent inactivation in response to the virtual Cai transient in the model, did not trigger SR Ca2+ release in the myocytes. Thus, endogenous Ca2+-sensitive currents in the myocyte, such as Na+/Ca2+ exchange and IKs, were not activated. One consequence was that EADs reconstituted after virtual ICa,L injection were smaller than before nifedipine blockade (Fig. 2): this could be corrected by injecting additional IKs via the dynamic clamp to simulate Ca2+-induced activation of IKs (Fig. 2 E). Importantly, whether or not additional IKs were injected, reduction of the noninactivated pedestal was equally potent at suppressing EADs and restoring the APD.
Off-target effects of nifedipine.
Our experimental approach required the full block of the endogenous ICa,L to correctly evaluate the EAD sensitivity to the relatively small ICa,L pedestal. We used 20 µM nifedipine, one of the most selective L-type Ca2+ channel blockers available. At the concentration used in this work, nifedipine may have had off-target effects, and possibly partially blocked Ito conductance (Gotoh et al., 1991). This effect may have contributed to the reduction of EAD amplitude, as observed in some of the experiments under dynamic clamp (e.g., Fig. 2 D); however, we were able to effectively restore EAD amplitude by the addition of a fraction of the computed IKs to the injected current (Fig. 2 E). We are confident that off-target effects of nifedipine have not biased the overall conclusion of this work, as the consequences of reducing ICa,L pedestal current were also tested and confirmed in pure computer simulations, presented in Fig. S4.
Despite its limitations, we believe that this approach outlines a useful new strategy for drug discovery, potentially adaptable to high throughput screening of small molecules or genetic interventions, to identify new antiarrhythmic agents. In this context, the dynamic-clamp approach represents a powerful method to move beyond simple screening for indiscriminate ion channel blockers and toward identifying and targeting subtle and selective aspects of ion channel biophysics to guide drug discovery.
We thank the members of the Olcese, Weiss, Qu, Garfinkel, and Karagueuzian laboratories for constructive discussions during the development of the project. We are also grateful to Maurizio Carnesecchi for contributing analytical software.
This work was supported by the National Heart, Lung and Blood Institute of the National Institutes of Health (NIH; P01HL78931 and R01 HL103662 to J.N. Weiss, and NIH/NIGMS R01GM082289 to R. Olcese), American Heart Association (WSA) Predoctoral Fellowship (10PRE3290025 to R.V. Madhvani), American Heart Association (NCRP) Scientist Development Grant (14SDG20300018 to A. Pantazis), and the Laubisch and Kawata endowments (to J.N. Weiss).
The authors declare no competing financial interests.
Richard L. Moss served as editor.
R.V. Madhvani and M. Angelini contributed equally to this paper.